16 Chinese vaccines undergoing clinical trials, 7 in phase III
CGTN
1612065546000

Packs of inactivated COVID-19 vaccine are seen at a packaging plant of Beijing Biological Products Institute Co Ltd on December 25, 2020. (Photo: Agencies)

China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase III trials and one has conditionally hit the market, said Wu Yuanbin, an official with the Ministry of Science and Technology, at a hematology conference on Saturday.